InsidersTradesSigma
Track the Genovis AB stock price and the full management transaction log of the company, a listed issuer based in Finland. Shares are listed on the FI market, under the oversight of FIN-FSA. Operating in the Healthcare & Pharma sector, Genovis AB has published 8 reports. Market capitalisation: €1.3bn. The latest transaction was disclosed on 15 May 2026 (Purchase). Among the most active insiders: Steven Jordan. The full history is free.
8
Insider Decl.
n/a
Thresholds
€155,849
6 ops.
Buy Volume
€1m
2 ops.
Sell Volume
32Σ signal
Fundamental score
Ranked 14,341 of 28,855 companies
52.2
score / 100
Value33
Quality71
FCF yld1.4%
Earn yld1.7%
EV/EBITDA33.4x
ROE7.5%
Gross mgn90%
Net mgn18%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 May 2026
Declarations8 total
4,146 shares@ €1.670.0005% mcap50.0% of flowAktieISIN SE0002485979FI:csv-3038ed09a69538b751f4
4,146 shares@ SEK 18.4490.0005% mcap100.0% of flowAktieISIN SE0002485979FI:A003Y639-1
2,470 shares@ €1.58930.0003% mcap100.0% of flowAktieISIN SE0002485979FI:A003W421-1
13,000 shares@ €1.63640.0016% mcap48.8% of flowAktieISIN SE0002485979FI:A003W055-1
38,340 shares@ €2.4640.0072% mcap100.0% of flowAktieISIN SE0002485979FI:A003O980-1
255,653 shares@ €2.34420.044% mcap52.5% of flowAktieISIN SE0002485979FI:A003O854-1
235,000 shares@ €2.30380.040% mcap47.5% of flowAktieISIN SE0002485979FI:A003M263-1
10,418 shares@ €2.14360.0016% mcap51.2% of flowAktieISIN SE0002485979FI:A003M248-1
8 of 8 declarations
About Genovis AB
Genovis AB is a company focused on developing technologies for biopharmaceuticals, particularly tools for antibody modification. It is listed on the XSTO exchange.
